Entero Therapeutics Inc (ENTO)
2.74
+0.11
(+4.18%)
USD |
NASDAQ |
May 31, 16:00
2.75
+0.01
(+0.36%)
After-Hours: 20:00
Entero Therapeutics Price to Book Value: 0.4656 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.4656 |
| May 30, 2024 | 0.4469 |
| May 29, 2024 | 0.4367 |
| May 28, 2024 | 0.4367 |
| May 24, 2024 | 0.4367 |
| May 23, 2024 | 0.4792 |
| May 22, 2024 | 0.50 |
| May 21, 2024 | 0.486 |
| May 20, 2024 | 0.4843 |
| May 17, 2024 | 0.5064 |
| May 16, 2024 | 0.503 |
| May 15, 2024 | 0.4809 |
| May 14, 2024 | 0.5047 |
| May 13, 2024 | 0.4573 |
| May 10, 2024 | 0.4359 |
| May 09, 2024 | 0.3529 |
| May 08, 2024 | 0.3479 |
| May 07, 2024 | 0.3304 |
| May 06, 2024 | 0.3254 |
| May 03, 2024 | 0.3254 |
| May 02, 2024 | 0.3492 |
| May 01, 2024 | 0.3554 |
| April 30, 2024 | 0.3304 |
| April 29, 2024 | 0.3354 |
| April 26, 2024 | 0.3429 |
| Date | Value |
|---|---|
| April 25, 2024 | 0.3416 |
| April 24, 2024 | 0.3779 |
| April 23, 2024 | 0.3905 |
| April 22, 2024 | 0.3642 |
| April 19, 2024 | 0.3254 |
| April 18, 2024 | 0.3554 |
| April 17, 2024 | 0.3629 |
| April 16, 2024 | 0.3779 |
| April 15, 2024 | 0.4092 |
| April 12, 2024 | 0.4155 |
| April 11, 2024 | 0.428 |
| April 10, 2024 | 0.428 |
| April 09, 2024 | 0.4568 |
| April 08, 2024 | 0.473 |
| April 05, 2024 | 0.4956 |
| April 04, 2024 | 0.5118 |
| April 03, 2024 | 0.4981 |
| April 02, 2024 | 0.5106 |
| April 01, 2024 | 0.5306 |
| March 28, 2024 | 2.462 |
| March 27, 2024 | 2.220 |
| March 26, 2024 | 2.176 |
| March 25, 2024 | 2.258 |
| March 22, 2024 | 2.422 |
| March 21, 2024 | 2.455 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3254
Minimum
Apr 19 2024
17.34
Maximum
Jun 03 2019
4.323
Average
3.614
Median
Price to Book Value Benchmarks
| BioVie Inc | 1.442 |
| Jaguar Health Inc | 1.720 |
| Benitec Biopharma Inc | 6.280 |
| Immuneering Corp | 0.5236 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 2.74 |
| Earnings Yield | -1.80K% |
| Market Cap | 7.535M |